Drugs / VXA-A1.1 H1 Tablet Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03121339 Comparator | Mar → May 2017 | — | Vaxart | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VXA-A1.1 H1 Tablet Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03121339 ↗ |
| Modality | Vaccine | “an adjuvanted adenoviral based influenza vaccine” NCT03121339 ↗ |
| Route | Oral | “Tableted oral H1 vaccine (\~140 mg tablet)” NCT03121339 ↗ |